Targeting protein synthesis control regions may reduce seizures in genetic epilepsy

Targeting the power of macromolecule synthesis successful the KCNQ2 cistron whitethorn service arsenic a imaginable disease-modifying strategy for patients with a familial signifier of neonatal-onset epilepsy and impaired encephalon development, according to a Northwestern Medicine survey published successful the Proceedings of the National Academy of Sciences.